[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351801-105":59,"doc-detail-351801-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","amplification-of-heterogeneous-nuclear-ribonucleoprotein-ab-aids-in-immune-infiltration-regulation-and-breast-cancer-tumorigenesis","Amplification of heterogeneous nuclear ribonucleoprotein A/B aids in immune infiltration regulation and breast cancer tumorigenesis","","Breast carcinoma is a prevalent malignancy in women worldwide, and reliable biomarkers are crucial for diagnosis and outcome prediction. This study analyzes breast cancer datasets from The Cancer Genome Atlas and Human Protein Atlas to assess HNRNPAB expression patterns and prognosis-associated features. Reverse transcription-quantitative PCR confirms HNRNPAB knockdown efficiency, while Transwell and CCK-8 assays show reduced migration, invasion, and proliferation after siRNA-mediated suppression. Bioinformatics links high HNRNPAB to tumor immune infiltration, signaling remodeling, cancer stem cell interactions, and immune microenvironment regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/amplification-of-heterogeneous-nuclear-ribonucleoprotein-ab-aids-in-immune-infiltration-regulation-and-breast-cancer-tumorigenesis/351801/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/amplification-of-heterogeneous-nuclear-ribonucleoprotein-ab-aids-in-immune-infiltration-regulation-and-breast-cancer-tumorigenesis/351801.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is HNRNPAB, and why is it relevant to breast cancer?","Question",{"text":112,"@type":113},"HNRNPAB is part of the HNRNP superfamily of RNA-binding proteins. The study investigates its role in breast carcinoma progression and its potential as a biomarker.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was HNRNPAB knockdown validated in breast cancer cell lines?",{"text":117,"@type":113},"Reverse transcription-quantitative PCR was used to validate the efficiency of HNRNPAB knockdown after siRNA-mediated intervention.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did HNRNPAB depletion have on breast cancer cells?",{"text":121,"@type":113},"HNRNPAB depletion suppressed proliferative activity, migratory potential, and invasive capabilities, as supported by Transwell assays and Cell Counting Kit-8 tests.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351801,1790488331,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","EXPERIMENTAL AND THERAPEUTIC MEDICINE 32: 198, 2026  \nAmplification of heterogeneous nuclear ribonucleoprotein A/B aids in immune infiltration regulation and breast cancer tumorigenesis  \nJIACHAO XU 1* , QIAN HAN2* , LIBIN CHEN 1 , MIN YANG 1 ,  \nJUN HUANG 1 , SHANHONG LIN 1 and SHENGMIN ZHANG 1  \n1Department of Ultrasound Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315500, P.R. China; 2Department of Neurosurgery, Shaoxing People's Hospital, Shaoxing, Zhejiang 312300, P.R. China  \nReceived February 11, 2026; Accepted April 17, 2026  \nDOI: 10. 3892/etm.2026.13193  \nAbstract. Breast carcinoma ranks among the most prevalent malignant tumors affecting women worldwide. The discovery of biomarkers is important in the diagnosis of breast cancer and the prediction of clinical outcomes in afflicted patients. Heterogeneous nuclear ribonucleoprotein (HNRNP)‑AB belongs to the extensive HNRNP superfamily; however, its exact role in the progression of breast carcinoma has not yet been fully clarified. The present study drew upon breast cancer sample datasets retrieved from The Cancer Genome Atlas and Human Protein Atlas databases to examine the expression patterns and prognosis‑associated data of HNRNPAB in clin‑ ical specimens. Reverse transcription‑quantitative PCR was employed to validate the efficiency of HNRNPAB knockdown in breast cancer cell lines. Transwell assays and Cell Counting Kit‑8 tests further demonstrated alterations in migratory, inva‑ sive and proliferative capacities following small interfering RNA‑mediated HNRNPAB knockdown. Bioinformatics was utilized to investigate numerous aspects of HNRNPAB in cancerous tissues, including its mRNA expression profile, prog‑ nostic value, signaling pathway remodeling, interaction with cancer stem cells and regulatory effects on the tumor immune microenvironment, as well as immunotherapeutic responses. Compared with normal breast tissues, HNRNPAB exhibited elevated expression in breast cancer tissues, upregulation that appeared to be associated with overall survival outcomes, sex characteristics, lymph node metastasis staging and adverse prognostic profiles in patients . Functionally, HNRNPAB depletion was found to suppress the proliferative activity, migratory potential and invasive capabilities of breast cancer  \nCorrespondence to: Ms. Shengmin Zhang, Department of Ultrasound Medicine, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Ningbo, Zhejiang 315500, P.R. China  \nE‑mail: [fyyzhangshengmin@nbu.edu.cn](fyyzhangshengmin@nbu.edu.cn)  \n*Contributed equally  \nKey words: heterogeneous nuclear ribonucleoprotein A/B, The Cancer Genome Atlas, biomarkers, breast cancer, immune  \ncells. Mechanistically, bioinformatics analyses indicated that high HNRNPAB expression was associated with the tumor immune infiltration status in affected individuals. In summary, the present study determined that HNRNPAB exerted a key regulatory effect on the development and progression of breast cancer and therefore its upregulation holds promise as a diag‑ nostic and prognostic marker. In addition, HNRNPAB serves a notable role in cancer immunotherapy, supporting its potential as a novel therapeutic candidate for the early detection and prognostic evaluation of breast cancer.  \nIntroduction  \nBreast carcinoma stands as a prevalent malignancy impacting women across the globe (1). Every year, there are 2.3 million new cases and 685,000 deaths. North America, Europe and Australia have the highest incidence rate, while Asia and parts of Africa have lower incidence rates (2) . It is worth noting that although relatively rare, BC can also affect men . This malignant tumor typically presents as a lump or lump in the breast, often accompanied by changes in shape, size or skin texture (3). The intricacy of molecular mechanisms that govern tumorigenesis and progression accounts for the heterogeneity inherent in breast cancer. From a molecular standpoint, such va","cbCaipcmQikM7ix1","https://ap.wps.com/l/cbCaipcmQikM7ix1","pdf",9290632,12,"English","# Introduction\n## Breast cancer burden and immune infiltration\n# Heterogeneous nuclear ribonucleoproteins (HNRNPs)\n## Roles in transcription and post-transcriptional regulation","[{\"question\":\"What is HNRNPAB, and why is it relevant to breast cancer?\",\"answer\":\"HNRNPAB is part of the HNRNP superfamily of RNA-binding proteins. The study investigates its role in breast carcinoma progression and its potential as a biomarker.\"},{\"question\":\"How was HNRNPAB knockdown validated in breast cancer cell lines?\",\"answer\":\"Reverse transcription-quantitative PCR was used to validate the efficiency of HNRNPAB knockdown after siRNA-mediated intervention.\"},{\"question\":\"What effects did HNRNPAB depletion have on breast cancer cells?\",\"answer\":\"HNRNPAB depletion suppressed proliferative activity, migratory potential, and invasive capabilities, as supported by Transwell assays and Cell Counting Kit-8 tests.\"}]","Amplification of heterogeneous nuclear ribonucleoprotein A/B aids in immune infiltration regulation and breast cancer tumorigenesis | PDF",1790095987,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c6a47acc195ad5d110c15d52e4812ba.webp",983,1357,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f2731ca3227580104a3b2fdd41a2eb9.webp",982,1356,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5b2d65362b8ebb1b4dd3059da6d71c1.webp",981,1354,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a972c6c534dce2a93572a4499870ee6b.webp",980,1353]